1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 14-cyclohexyl-6[2-(dimethylamino)ethyl]-N-(morpholin-4-ylsulfonyl)-5,6,7,8-tetrahydroindolo[2,1-a][2,5]benzodiazocine-11-carboxamide

반응식

[Cl-].[Cl-].[C:3]([C:6]1[CH:7]=[CH:8][C:9]2[C:10]([CH:30]3[CH2:35][CH2:34][CH2:33][CH2:32][CH2:31]3)=[C:11]3[C:18]4[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=4[CH2:16][NH+:15]([CH2:23][CH2:24][NH+:25]([CH3:27])[CH3:26])[CH2:14][CH2:13][N:12]3[C:28]=2[CH:29]=1)(O)=[O:4].[N:36]1([S:42]([NH2:45])(=[O:44])=[O:43])[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1.CCN=C=NCCCN(C)C>CN(C1C=CN=CC=1)C>[CH:30]1([C:10]2[C:9]3[CH:8]=[CH:7][C:6]([C:3]([NH:45][S:42]([N:36]4[CH2:41][CH2:40][O:39][CH2:38][CH2:37]4)(=[O:44])=[O:43])=[O:4])=[CH:29][C:28]=3[N:12]3[CH2:13][CH2:14][N:15]([CH2:23][CH2:24][N:25]([CH3:26])[CH3:27])[CH2:16][C:17]4[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=4[C:11]=23)[CH2:35][CH2:34][CH2:33][CH2:32][CH2:31]1